Projekt

Phase III international, randomized study of Trabectedin plus Pegylated Liposomal Doxorubicin (PLD) versus Car-boplatin plus PLD in patients with ovarian cancer progress-ing within 6-12 months of last platinum

Automatisch geschlossen · 2014 bis 2021